These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24293351)

  • 1. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN loss and KRAS activation cooperate in murine biliary tract malignancies.
    Marsh V; Davies EJ; Williams GT; Clarke AR
    J Pathol; 2013 Jun; 230(2):165-73. PubMed ID: 23483557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
    Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
    J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA.
    Xia RM; Liu T; Li WG; Xu XQ
    Clin Transl Med; 2021 Oct; 11(10):e383. PubMed ID: 34709758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer.
    Marsh Durban V; Jansen M; Davies EJ; Morsink FH; Offerhaus GJ; Clarke AR
    Am J Pathol; 2014 Jan; 184(1):86-91. PubMed ID: 24200851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 activates the β-catenin pathway to cause intestinal neoplasia.
    Santaolalla R; Sussman DA; Ruiz JR; Davies JM; Pastorini C; España CL; Sotolongo J; Burlingame O; Bejarano PA; Philip S; Ahmed MM; Ko J; Dirisina R; Barrett TA; Shang L; Lira SA; Fukata M; Abreu MT
    PLoS One; 2013; 8(5):e63298. PubMed ID: 23691015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis.
    Welz L; Kakavand N; Hang X; Laue G; Ito G; Silva MG; Plattner C; Mishra N; Tengen F; Ogris C; Jesinghaus M; Wottawa F; Arnold P; Kaikkonen L; Stengel S; Tran F; Das S; Kaser A; Trajanoski Z; Blumberg R; Roecken C; Saur D; Tschurtschenthaler M; Schreiber S; Rosenstiel P; Aden K
    Gastroenterology; 2022 Jan; 162(1):223-237.e11. PubMed ID: 34599932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
    Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
    Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flat serrated adenomas of the colorectal mucosa.
    Rubio CA; Jaramillo E
    Jpn J Cancer Res; 1996 Mar; 87(3):305-9. PubMed ID: 8613434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
    Richards JS; Fan HY; Liu Z; Tsoi M; Laguë MN; Boyer A; Boerboom D
    Oncogene; 2012 Mar; 31(12):1504-20. PubMed ID: 21860425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
    Najumudeen AK; Ceteci F; Fey SK; Hamm G; Steven RT; Hall H; Nikula CJ; Dexter A; Murta T; Race AM; Sumpton D; Vlahov N; Gay DM; Knight JRP; Jackstadt R; Leach JDG; Ridgway RA; Johnson ER; Nixon C; Hedley A; Gilroy K; Clark W; Malla SB; Dunne PD; Rodriguez-Blanco G; Critchlow SE; Mrowinska A; Malviya G; Solovyev D; Brown G; Lewis DY; Mackay GM; Strathdee D; Tardito S; Gottlieb E; ; Takats Z; Barry ST; Goodwin RJA; Bunch J; Bushell M; Campbell AD; Sansom OJ
    Nat Genet; 2021 Jan; 53(1):16-26. PubMed ID: 33414552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer.
    Maitra R; Thavornwatanayong T; Venkatesh MK; Chandy C; Vachss D; Augustine T; Guzik H; Koba W; Liu Q; Goel S
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice.
    Foth M; Ahmad I; van Rhijn BW; van der Kwast T; Bergman AM; King L; Ridgway R; Leung HY; Fraser S; Sansom OJ; Iwata T
    J Pathol; 2014 Jun; 233(2):148-58. PubMed ID: 24519156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Liu J; Shen W; Cheng H; Fan M; Xiao J; Xu C; Tan J; Lai Y; Yu C; Sun D; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1452-1461. PubMed ID: 36329578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Apc
    Guo B; Zheng Y; Fan Y; Yang Y; Wang Y; Qin L; An Y; Xu X; Zhang X; Sun G; Dou H; Shao C; Gong Y; Jiang B; Hu H
    Neoplasia; 2024 Jul; 53():101005. PubMed ID: 38761506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.
    Vande Voorde J; Steven RT; Najumudeen AK; Ford CA; Dexter A; Gonzalez-Fernandez A; Nikula CJ; Xiang Y; Ford L; Maneta Stavrakaki S; Gilroy K; Zeiger LB; Pennel K; Hatthakarnkul P; Elia EA; Nasif A; Murta T; Manoli E; Mason S; Gillespie M; Lannagan TRM; Vlahov N; Ridgway RA; Nixon C; Raven A; Mills M; Athineos D; Kanellos G; Nourse C; Gay DM; Hughes M; Burton A; Yan B; Sellers K; Wu V; De Ridder K; Shokry E; Huerta Uribe A; Clark W; Clark G; Kirschner K; Thienpont B; Li VSW; Maddocks ODK; Barry ST; Goodwin RJA; Kinross J; Edwards J; Yuneva MO; Sumpton D; Takats Z; Campbell AD; Bunch J; Sansom OJ
    Nat Metab; 2023 Aug; 5(8):1303-1318. PubMed ID: 37580540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
    Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis.
    Tsumuraya H; Okayama H; Katagata M; Matsuishi A; Fukai S; Ito M; Sakamoto W; Saito M; Momma T; Nakajima S; Mimura K; Kono K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
    Jackstadt R; van Hooff SR; Leach JD; Cortes-Lavaud X; Lohuis JO; Ridgway RA; Wouters VM; Roper J; Kendall TJ; Roxburgh CS; Horgan PG; Nixon C; Nourse C; Gunzer M; Clark W; Hedley A; Yilmaz OH; Rashid M; Bailey P; Biankin AV; Campbell AD; Adams DJ; Barry ST; Steele CW; Medema JP; Sansom OJ
    Cancer Cell; 2019 Sep; 36(3):319-336.e7. PubMed ID: 31526760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
    Najumudeen AK; Fey SK; Millett LM; Ford CA; Gilroy K; Gunduz N; Ridgway RA; Anderson E; Strathdee D; Clark W; Nixon C; Morton JP; Campbell AD; Sansom OJ
    Nat Commun; 2024 Jan; 15(1):100. PubMed ID: 38168062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.